Entry Detail



General Information

Database ID:exR0761098
RNA Name:NCL
RNA Type:mRNA
Chromosome:chr2
Starnd:-
Coordinate:
Start Site(bp):231453531End Site(bp):231483641
External Links:ENSG00000115053



Disease Information

Disease Name:Glioblastoma Multiforme
Disease Category:Cancers
MeSH ID:D005909
Type:Neoplasms/Neoplasms, Glandular and Epithelial
Alias:Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell



Expression Detail

GEO ID:GSE106804
Description:Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles
Experimental Design:Cancer vs Control
Case Disease Type:Glioblastoma Multiforme
Case Disease SubType:NA
Case Sample:Glioblastoma Multiforme
Control Sample:Healthy
Number of Case:13
Number of Control:6
Number of Samples:19





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC005258.1
chr19
2269525
2341172
+
ADCYAP1R1
chr7
31052461
31111479
+
AKR1B1
chr7
134442356
134459284
-
AC027796.3
chr17
3585149
3636249
-
AGPAT1
chr6
32168212
32178096
-
AC006064.6
chr12
6556886
6607367
-
AL136295.5
chr14
24147548
24166452
+
ACACA
chr17
37084992
37406836
-
AC093525.2
chr16
2496032
2520218
+
ABHD12
chr20
25294742
25390835
-
ADPRH
chr3
119579268
119589945
+
AC018523.2
chr11
14493783
14520344
-
AGPAT5
chr8
6708642
6761503
+
AKAP8
chr19
15353385
15379798
-
AC245033.1
chr15
82536788
82573194
-
ABCD1
chrX
153724856
153744755
+
ABCF1
chr6
30571393
30597179
+
AFF4
chr5
132875395
132963634
-
AFAP1
chr4
7758714
7939926
-
AFTPH
chr2
64524305
64593005
+
ALDOA
chr16
30064164
30070457
+
AC013394.1
chr15
92883413
92949230
+
ACTG1
chr17
81509971
81523847
-
ADGRG6
chr6
142301854
142446266
+
ACKR3
chr2
236567787
236582354
+
ADAR
chr1
154582057
154628013
-
AC023055.1
chr12
55757275
55827546
-
AHCY
chr20
34280268
34311802
-
AC009690.1
chr15
72284727
72375981
-
ACAP1
chr17
7336529
7351477
+
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC007780.1
chr17
68413623
68524949
+
AC016876.2
chr17
7581964
7584086
-
AC020663.1
chr16
4730115
4752565
-
AC023509.1
chr12
53441741
53467528
+
AC023908.3
chr15
39782571
39785617
+
AC026461.1
chr16
56682470
56687807
+
AC064802.1
chr8
114282067
114295839
+
AC092143.2
chr16
89919827
89922662
-
AC106864.1
chr4
112693047
112706810
-
AC245033.4
chr15
82533175
82540008
-
AL034346.1
chr6
1383790
1385066
-
AL137129.1
chr14
61734138
61776260
+
Display:



Experiment Detail

GEO ID:NA
Sample Source:NA
Source Fraction:NA
Platform:NA
Method:NA
Num of detected RNA Type:NA
Num of detected RNAs of this Type:NA
Sample treatment protocol:NA
RNA Extract protocol:NA
RNA library preparation protocol:NA



Reference

PMID:29330365
Title:Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles.
Author:Re¨¢tegui E, van der Vos KE, Lai CP, Zeinali M, Atai NA, Aldikacti B, Floyd FP Jr, H Khankhel A, Thapar V, Hochberg FH, Sequist LV, Nahed BV, S Carter B, Toner M, Balaj L, T Ting D, Breakefield XO, Stott SL.
Journal:Nat Commun. 2018 Jan 12;9(1):175.
Description:Tumor-derived EVs have the potential to be utilized as disease-specific biomarkers, and genes specific to GBM as well as transcripts that are hallmarks for the four genetic subtypes of the disease.